IL208026A0 - Macrocyclic lactone compounds and methods for their use - Google Patents

Macrocyclic lactone compounds and methods for their use

Info

Publication number
IL208026A0
IL208026A0 IL208026A IL20802610A IL208026A0 IL 208026 A0 IL208026 A0 IL 208026A0 IL 208026 A IL208026 A IL 208026A IL 20802610 A IL20802610 A IL 20802610A IL 208026 A0 IL208026 A0 IL 208026A0
Authority
IL
Israel
Prior art keywords
methods
macrocyclic lactone
lactone compounds
compounds
macrocyclic
Prior art date
Application number
IL208026A
Original Assignee
Elixir Medical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elixir Medical Corp filed Critical Elixir Medical Corp
Publication of IL208026A0 publication Critical patent/IL208026A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL208026A 2008-03-11 2010-09-06 Macrocyclic lactone compounds and methods for their use IL208026A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2008/056501 WO2009114010A1 (en) 2008-03-11 2008-03-11 Macrocyclic lactone compounds and methods for their use

Publications (1)

Publication Number Publication Date
IL208026A0 true IL208026A0 (en) 2010-12-30

Family

ID=41065507

Family Applications (1)

Application Number Title Priority Date Filing Date
IL208026A IL208026A0 (en) 2008-03-11 2010-09-06 Macrocyclic lactone compounds and methods for their use

Country Status (6)

Country Link
EP (1) EP2254412A4 (en)
JP (1) JP2011525890A (en)
CN (1) CN102215682A (en)
BR (1) BRPI0822405A8 (en)
IL (1) IL208026A0 (en)
WO (1) WO2009114010A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8088789B2 (en) 2006-09-13 2012-01-03 Elixir Medical Corporation Macrocyclic lactone compounds and methods for their use
US10695327B2 (en) 2006-09-13 2020-06-30 Elixir Medical Corporation Macrocyclic lactone compounds and methods for their use
US10307292B2 (en) 2011-07-18 2019-06-04 Mor Research Applications Ltd Device for adjusting the intraocular pressure
CN103387572B (en) * 2013-07-17 2015-09-30 成都雅途生物技术有限公司 Everolimus defects inspecting reference marker and preparation method thereof
CN107759616B (en) * 2016-08-23 2020-11-17 上海微创医疗器械（集团）有限公司 Compound and preparation method and application thereof
US11654036B2 (en) 2020-05-26 2023-05-23 Elixir Medical Corporation Anticoagulant compounds and methods and devices for their use
CN113801104B (en) * 2020-06-15 2023-12-08 鲁南制药集团股份有限公司 Preparation method of hydrolysis impurity of ivermectin Mo Sida cyclic lactone

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA935112B (en) * 1992-07-17 1994-02-08 Smithkline Beecham Corp Rapamycin derivatives
GB9221220D0 (en) * 1992-10-09 1992-11-25 Sandoz Ag Organic componds
WO1994012655A1 (en) * 1992-11-20 1994-06-09 Smithkline Beecham Corporation Process for producing rapamycin derivatives
US20070059336A1 (en) * 2004-04-30 2007-03-15 Allergan, Inc. Anti-angiogenic sustained release intraocular implants and related methods
WO2006108065A2 (en) * 2005-04-05 2006-10-12 Elixir Medical Corporation Degradable implantable medical devices
PL1904056T3 (en) * 2005-07-18 2009-09-30 Minu Llc Use of a macrolide to restore corneal sensation
US20070014760A1 (en) * 2005-07-18 2007-01-18 Peyman Gholam A Enhanced recovery following ocular surgery
WO2008033956A2 (en) * 2006-09-13 2008-03-20 Elixir Medical Corporation Macrocyclic lactone compounds and methods for their use

Also Published As

Publication number Publication date
WO2009114010A1 (en) 2009-09-17
JP2011525890A (en) 2011-09-29
EP2254412A1 (en) 2010-12-01
BRPI0822405A8 (en) 2018-06-05
EP2254412A4 (en) 2012-05-09
CN102215682A (en) 2011-10-12
BRPI0822405A2 (en) 2018-05-15

Similar Documents

Publication Publication Date Title
EP2083834A4 (en) Macrocyclic lactone compounds and methods for their use
EP2352459A4 (en) Macrocyclic lactone compounds and methods for their use
ZA201202516B (en) Macrocyclic integrase inhibitors
IL201836A0 (en) Pyrrolopyridine derivatives and their use as bace inhibitors
EP2259796A4 (en) Materials and methods for improved immunoglycoproteins
GB0818241D0 (en) Compounds and their use
EP2416657A4 (en) Substituted di-arylhydantoin and di-arylthiohydantoin compounds and methods for use thereof
EP2320734A4 (en) Flavin derivatives
IL208081A0 (en) Amido - thiophene compounds and their use
IL212285A0 (en) Azaindole derivatives
EP2308884A4 (en) Method for producing -hetero-substituted alkylhalohydrosilane and use thereof
EP2331543A4 (en) 3-deazaneplanocin derivatives
EP2291078A4 (en) Oxazolobenzimidazole derivatives
ZA201102123B (en) Substituted triazolo-pyridazine derivatives
EP2279532A4 (en) Oxazolobenzimidazole derivatives
ZA201007395B (en) Aryl-quinolyl compounds and their use
EP2457126A4 (en) Method and materials for double patterning
PL2344449T3 (en) Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use
EP2470513A4 (en) Macrocyclic hopo chelators
EP2624834A4 (en) Macrocyclic lactone compounds and methods for their use
IL208771A0 (en) Iminopyridine derivatives and use thereof
IL208026A0 (en) Macrocyclic lactone compounds and methods for their use
ZA201100850B (en) Rolling apparatus
EP2292613A4 (en) Dihydroindolinone derivatives
HK1153465A1 (en) Macrocyclic compounds and methods of treatment